Miriam Kolko

Miriam Kolko

Clinical Associate Professor, Professor

Member of:

  • Ophthalmology

ORCID: 0000-0001-8697-0734

Publication year:
All
31 - 40 out of 162Page size: 10
  1. 2022
  2. Published

    Topical glaucoma medications: Clinical implications for the ocular surface

    Fineide, F., Lagali, N., Adil, M. Y., Arita, R., Kolko, Miriam, Vehof, J. & Utheim, T. P., 2022, In: Ocular Surface. 26, p. 19-49

    Research output: Contribution to journal › Review › Research › peer-review

  3. Published

    Girl Power in Glaucoma: The Role of Estrogen in Primary Open Angle Glaucoma

    Fotesko, K., Thomsen, B. S. V., Kolko, Miriam & Vohra, Rupali, 2022, In: Cellular and Molecular Neurobiology. 42, p. 41–57

    Research output: Contribution to journal › Review › Research › peer-review

  4. Published

    An Evaluation of the Physicochemical Properties of Preservative-Free 0.005% (w/v) Latanoprost Ophthalmic Solutions, and the Impact on In Vitro Human Conjunctival Goblet Cell Survival

    Freiberg, Josefine, Nagstrup, Anne Hedengran, Heegaard, Steffen, Petrovski, G., Jacobsen, Jette, Cvenkel, B. & Kolko, Miriam, 2022, In: Journal of Clinical Medicine. 11, 11, 3137.

    Research output: Contribution to journal › Journal article › Research › peer-review

  5. Published

    IL-4 and IL-13 both contribute to the homeostasis of human conjunctival goblet cells in vitro

    Hansen, Pernille May, Tollenaere, M. A. X., Nagstrup, Anne Hedengran, Heegaard, Steffen, Amoudruz, P., Røpke, M., Thyssen, Jacob Pontoppidan, Kolko, Miriam & Norsgaard, H., 2022, In: Allergy: European Journal of Allergy and Clinical Immunology. 77, 8, p. 2555-2558

    Research output: Contribution to journal › Letter › Research › peer-review

  6. Published

    Biosimilars and generic medications in ophthalmology

    Harris, A., Wirostko, B., Rowe-Rendleman, C. L., Siesky, B., Verticchio Vercellin, A. C., Ciulla, T. A., Wentz, S., Finnen, N. P., Kolko, Miriam & Januleviciene, I., 2022, Kugler Publications. 94 p.

    Research output: Book/Report › Anthology › Research › peer-review

  7. Published

    Generic benzalkonium chloride‐preserved travoprost eye drops are not identical to the branded polyquarternium‐1‐preserved travoprost eye drop: Effect on cultured human conjunctival goblet cells and their physicochemical properties

    Nagstrup, Anne Hedengran, Freiberg, Josefine, Hansen, Pernille May, Jacobsen, Jette, Larsen, Susan Weng, Rønholt, Stine, Freude, Kristine, Boix‐lemonche, G., Petrovski, G., Heegaard, Steffen & Kolko, Miriam, 2022, In: Acta Ophthalmologica. 100, 7, p. 819-827

    Research output: Contribution to journal › Journal article › Research › peer-review

  8. Published

    Glucagon-Like Peptide 1 Receptor Agonists – Potential Game Changers in the Treatment of Glaucoma?

    Mouhammad, Zaynab Ahmad, Vohra, Rupali, Horwitz, Anna, Thein, A. S., Rovelt, Jens, Cvenkel, B., Williams, P. A., Azuara-Blanco, A. & Kolko, Miriam, 2022, In: Frontiers in Neuroscience. 16, 824054.

    Research output: Contribution to journal › Review › Research › peer-review

  9. Published

    The physicochemical properties of preserved and preservative-free latanoprost eye drops and their impact on human conjunctival goblet cells

    Müllertz, O. A. O., Nagstrup, Anne Hedengran, Mouhammad, Zaynab Ahmad, Freiberg, Josefine, Nagymihály, R., Jacobsen, Jette, Larsen, Susan Weng, Bair, J. A., Utheim, T. P., Dartt, D. A., Heegaard, Steffen, Petrovski, G. & Kolko, Miriam, 2022, In: Acta Ophthalmologica. 100, S267

    Research output: Contribution to journal › Conference abstract in journal › Research › peer-review

  10. Published

    Correction to: Switching to Preservative-Free Tafluprost/Timolol Fixed-Dose Combination in the Treatment of Open-Angle Glaucoma or Ocular Hypertension: Subanalysis of Data from the VISIONARY Study According to Baseline Monotherapy Treatment (Advances in Therapy, (2022), 39, 8, (3501-3521), 10.1007/s12325-022-02166-6)

    The VISIONARY Study Group, T. V. S. G., 2022, In: Advances in Therapy. 39, 8, p. 3522-3523 2 p.

    Research output: Contribution to journal › Comment/debate › Research › peer-review

  11. Published

    Switching to Preservative-Free Tafluprost/Timolol Fixed-Dose Combination in the Treatment of Open-Angle Glaucoma or Ocular Hypertension: Subanalysis of Data from the VISIONARY Study According to Baseline Monotherapy Treatment

    The VISIONARY Study Group, T. V. S. G., 2022, In: Advances in Therapy. 39, 8, p. 3501-3521

    Research output: Contribution to journal › Journal article › Research › peer-review

Previous 1 2 3 4 5 6 7 8 ...17 Next

ID: 14599192